UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 397

Sortiert nach

Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2013-10, Vol.24 Suppl 6, p.vi125-vi132

2013

Volltextzugriff (PDF)

Frequent PD-L1 expression in testicular germ cell tumors

British journal of cancer, 2015-07, Vol.113 (3), p.411-413

2015

Volltextzugriff (PDF)

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)

Annals of oncology, 2016-07, Vol.27 (7), p.1299-1304

2016

Volltextzugriff (PDF)

Surveillance versus adjuvant radiotherapy for patients with high‐risk stage I seminoma

Cancer, 2017-04, Vol.123 (7), p.1212-1218

2017

Volltextzugriff (PDF)

The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis

European urology, 2020-03, Vol.77 (3), p.344-351

2020

Volltextzugriff (PDF)

Future of testicular germ cell tumor incidence in the United States: Forecast through 2026

Cancer, 2017-06, Vol.123 (12), p.2320-2328

2017

Volltextzugriff (PDF)

Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance

Cancer medicine (Malden, MA), 2015-01, Vol.4 (1), p.155-160

2015

Volltextzugriff (PDF)

International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973–2007

Andrology (Oxford), 2015-01, Vol.3 (1), p.4-12

2015

Volltextzugriff (PDF)

Changes in epidemiologic features of testicular germ cell cancer: Age at diagnosis and relative frequency of seminoma are constantly and significantly increasing

Urologic oncology, 2014, Vol.32 (1), p.33.e1-33.e6

2014

Volltextzugriff (PDF)

Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First Presentation

Urologia internationalis, 2018-01, Vol.100 (4), p.409-419

2018

Volltextzugriff (PDF)

Testicular cancer in Europe and the USA: survival still rising among older patients

Annals of oncology, 2013-02, Vol.24 (2), p.508-513

2013

Volltextzugriff (PDF)

Recent trends in the incidence of testicular germ cell tumors in the United States

Andrology (Oxford), 2015-01, Vol.3 (1), p.13-18

2015

Volltextzugriff (PDF)

Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors

Clinical genitourinary cancer, 2019-10, Vol.17 (5), p.e1026-e1035

2019

Volltextzugriff (PDF)

Current knowledge of risk factors for testicular germ cell tumors

International journal of urology, 2018-04, Vol.25 (4), p.337-344

2018

Volltextzugriff (PDF)

INCREASED INCIDENCE OF TESTICULAR CANCER IN MEN PRESENTING WITH INFERTILITY AND ABNORMAL SEMEN ANALYSIS

The Journal of urology, 2005-11, Vol.174 (5), p.1819-1822

2005

Volltextzugriff (PDF)

Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association

International journal of urology, 2014-08, Vol.21 (8), p.S1-S6

2014

Volltextzugriff (PDF)

Primary mediastinal germ cell tumours with high prevalence of somatic malignancy: An experience from a single tertiary care oncology centre

Annals of diagnostic pathology, 2021-08, Vol.53, p.151763, Article 151763

2021

Volltextzugriff (PDF)

Testicular cancer among US men aged 50 years and older

Cancer epidemiology, 2018-08, Vol.55, p.68-72

2018

Volltextzugriff (PDF)

Patterns of care and outcomes of men with germ cell tumors in a high‐volume Australian center

Asia-Pacific journal of clinical oncology, 2022-04, Vol.18 (2), p.e23-e31

2022

Volltextzugriff (PDF)

Malignant germ cell tumors in men aged 50 years and over are associated with adverse pathologic features and higher stage at presentation

Annals of diagnostic pathology, 2023-02, Vol.62, p.152070, Article 152070

2023

Volltextzugriff (PDF)

Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study

Annals of oncology, 2017-03, Vol.28 (3), p.576-582

2017

Volltextzugriff (PDF)

A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania

Medicina (Kaunas, Lithuania), 2019-08, Vol.55 (9), p.552

2019

Volltextzugriff (PDF)

Age‐incidence patterns of seminoma and nonseminoma among males and females in Germany and the United States, 2008–2016

Andrology (Oxford), 2023-01, Vol.11 (1), p.65-72

2023

Volltextzugriff (PDF)

Trends in the incidence of testicular germ cell tumors in the United States

Cancer, 2003-01, Vol.97 (1), p.63-70

2003

Volltextzugriff (PDF)

Familial risk in testicular cancer as a clue to a heritable and environmental aetiology

British journal of cancer, 2004-05, Vol.90 (9), p.1765-1770

2004

Volltextzugriff (PDF)

1 – 25 von 397

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(324)

Publikationsform

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Male
(377)
Humans
(376)
Science & Technology
(332)
Life Sciences & Biomedicine
(324)
Adult
(275)
Testicular Neoplasms - Epidemiology
(231)
Seminoma
(193)
Oncology
(185)
Middle Aged
(181)
Seminoma - Epidemiology
(181)
Testicular Neoplasms - Pathology
(158)
Tumors
(155)
Adolescent
(142)
Testicular Cancer
(139)
Seminoma - Pathology
(128)
Incidence
(126)
Risk Factors
(126)
Biological And Medical Sciences
(121)
Medical Sciences
(121)
Aged
(104)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Frequent PD-L1 expression in testicular germ cell tumors

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)

Surveillance versus adjuvant radiotherapy for patients with high‐risk stage I seminoma

The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis

Future of testicular germ cell tumor incidence in the United States: Forecast through 2026

Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance

International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973–2007

Changes in epidemiologic features of testicular germ cell cancer: Age at diagnosis and relative frequency of seminoma are constantly and significantly increasing

Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First Presentation

Testicular cancer in Europe and the USA: survival still rising among older patients

Recent trends in the incidence of testicular germ cell tumors in the United States

Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors

Current knowledge of risk factors for testicular germ cell tumors

INCREASED INCIDENCE OF TESTICULAR CANCER IN MEN PRESENTING WITH INFERTILITY AND ABNORMAL SEMEN ANALYSIS

Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: The first large-scale study from the Cancer Registration Committee of the Japanese Urological Association

Primary mediastinal germ cell tumours with high prevalence of somatic malignancy: An experience from a single tertiary care oncology centre

Testicular cancer among US men aged 50 years and older

Patterns of care and outcomes of men with germ cell tumors in a high‐volume Australian center

Malignant germ cell tumors in men aged 50 years and over are associated with adverse pathologic features and higher stage at presentation

Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study

A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania

Age‐incidence patterns of seminoma and nonseminoma among males and females in Germany and the United States, 2008–2016

Trends in the incidence of testicular germ cell tumors in the United States

Familial risk in testicular cancer as a clue to a heritable and environmental aetiology

Suchergebnisse filtern